Sang-Cheul Oh

2.6k citations
6 papers · 1.9k · 1 hit paper · h-index 6

Impact in

Papers in

Sang-Cheul Oh

6 papers receiving 1.8k citations

Sang-Cheul Oh's Hit Papers

Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial 2014 · 1.7k citations
1.7k0+4+8Years since publication50010001.5k

Peers

Sang-Cheul Oh
Comparison fields: 5 of 71
  • Gastroenterology 287
  • Pulmonary and Respiratory Medicine 1.0k
  • Oncology 684
  • Surgery 442
  • Pathology and Forensic Medicine 142
Replace Roberto Carlesi with:
Roberto Carlesi Italy
Kumari Chandrawansa United States
Ta-Sen Yeh Taiwan
M Fodor Chile
Aiwen Wu China
Jan J. Koornstra Netherlands
Adriano Rodrigues Portugal
G. Kurteva United States
Elena Elimova Canada
Peter Grimminger Germany
Sang-Cheul Oh relative to Roberto Carlesi Italy Roberto Carlesi's profile →
Citations per field
00.5×1.5×
Roberto Carlesi · 1×
Citations per year

Countries citing papers authored by Sang-Cheul Oh

Since Specialization
Citations

This map shows the geographic impact of Sang-Cheul Oh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sang-Cheul Oh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sang-Cheul Oh more than expected).

Fields of papers citing papers by Sang-Cheul Oh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sang-Cheul Oh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sang-Cheul Oh. The network helps show where Sang-Cheul Oh may publish in the future.

Co-authors

The 25 scholars most cited alongside Sang-Cheul Oh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sang-Cheul Oh Line = papers co-authored together Sang-Cheul Oh links everyone, so they are left out of the graph.

All Works

6 of 6 papers shown
#Work
1
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
Hit paper breakdown →
20141743
2 201750
3 200618
4 202215
5 202214
6 202312

About Sang-Cheul Oh

Sang-Cheul Oh is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Pathology and Forensic Medicine and Cancer Research, having authored 6 papers that have together received 1.9k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (2 papers), Ubiquitin and proteasome pathways (1 paper), NF-κB Signaling Pathways (1 paper), Cancer-related gene regulation (1 paper), Wnt/β-catenin signaling in development and cancer (1 paper), Genetic factors in colorectal cancer (1 paper), Colorectal Cancer Screening and Detection (1 paper) and Cell death mechanisms and regulation (1 paper). The work is most often cited by research in Gastroenterology (287 citations), Pulmonary and Respiratory Medicine (1.0k citations), Oncology (684 citations), Surgery (442 citations) and Pathology and Forensic Medicine (142 citations). Sang-Cheul Oh has collaborated with scholars based in South Korea, Hungary and Belgium. Frequent co-authors include Eric Van Cutsem, Atsushi Ohtsu, David Ferry, Yasuhiro Shimada, H. Wilke, Michael Emig, Kumari Chandrawansa, Kei Muro, G. Bodoky and Shuichi Hironaka. Their work appears in journals such as Cancer Gene Therapy, The Lancet Oncology, Cancers, Annals of Surgical Oncology and Journal of the Korean Gastric Cancer Association.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact